DiaMedica Therapeutics vs Enterome
DiaMedica Therapeutics vs Enterome, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: DiaMedica Therapeutics is on 35/100 and Enterome on 60/100.
Where each one leads
DiaMedica Therapeutics
- agent readiness: 47/100 against 21/100
Enterome
- our overall score: 60/100 against 35/100
- domain rating: 46/100 against 34/100
- funding raised: $124M against $30.1M
At a glance
| Measure | DiaMedica Therapeutics | Enterome |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases. | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. |
| Category | Biotechnology, Healthcare, Pharmaceuticals | Biotechnology, Drug Discovery, Oncology, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Software | hardware | services | marketplace | platform |
| Founded | 2000 | 2012 |
| Headquarters | Minneapolis, United States | Paris, France |
| Status | Active | Active |
Size, funding and growth
| Measure | DiaMedica Therapeutics | Enterome |
|---|---|---|
| Employees | Not published | 33 |
| Total funding | $30.1M | $124M |
| Latest round | Private Placement | Later Stage VC |
| LinkedIn followers | Not published | 16,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | DiaMedica Therapeutics | Enterome |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 60/100 |
| Traction | 37/100 | 55/100 |
| Team | Not published | 70/100 |
| Search visibility | 11/100 | 34/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | DiaMedica Therapeutics | Enterome |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4, Segment |
DiaMedica Therapeutics vs Enterome: common questions
Which is better, DiaMedica Therapeutics or Enterome?
On our 0-100 score Enterome rates higher (60/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do DiaMedica Therapeutics and Enterome compare on the numbers?
DiaMedica Therapeutics leads on agent readiness (47/100 against 21/100). Enterome leads on our overall score (60/100 against 35/100), domain rating (46/100 against 34/100), funding raised ($124M against $30.1M).
Read the full DiaMedica Therapeutics review and pricing or the Enterome review and pricing. You can also browse other DiaMedica Therapeutics alternatives we track.